Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection

Autores
Ferragut, Fatima Eneida del Valle; Parket, Robert; Ternette, Nicola; Nielsen, Morten; Gomez, Karina Andrea
Año de publicación
2023
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
T lymphocyte-mediated immune response against Trypanosoma cruzi (T. cruzi), the parasite causing Chagas disease, is relevant for both parasite control and disease pathogenesis. Therefore, the study of T cells results crucial to the understanding of the immune response in patients and thus contribute to the development of therapies and/or vaccines. However, many challenges are faced when attempting to identify T cell epitopes that can be used for diagnostic or preventive purposes. The complexity of the parasite-host interactions added to the large T. cruzi proteome and the diversity of human leukocyte antigen (HLA) haplotypes in humans hamper the characterization of T cellactivating epitopes, with high population coverage. To date, only a limit number of T. cruzi T cell antigens have been described and only a small proportion of HLA population diversity has been covered. To facilitate this issue, we profiled the repertoire of HLA class I and class II-bound peptides presented by human monocyte-derived macrophages infected or not with T. cruzi. Herein we purified HLA-peptide complexes from infected and uninfected cells and characterized the peptide ligands using LC/MS. For this subset of peptides, the binding to HLA class I and II alleles from THP-1 haplotype was predicted by using MHCMotifDecon1.1, NetMHCpan 4.1a and NetMHCIIpan 4.2 algorithms based on artificial neural network trained with empirical HLA binding and immunopeptidomics data. Our approach allowed us to identify 66 T. cruzi encoded ligands originating from 37 proteins, many of them outside TS proteins and with intracellular localization. Additionally, results showed no difference in length between T. cruzi and uninfected host ligands, thus suggesting that the parasite does not alter antigen processing and presentation machinery in the host cell. For T. cruzi source proteins, 8-12-mer and 12-21-mer peptides were extracted for HLA class I and II, respectively. Binding to a set of 19 HLA-A, 28 HLA-B, 19 HLA-C molecules prevalent in Latin America and 28 HLA-DRB1 alleles, 13 HLADPA1/DPB1 and 36 HLA-DQA1/DQB1 haplotypes were predicted using NetMHCpan 4.1 and NetMHCIIpan 4.1 methods, respectively. Finally, we selected 2 sets of 50 peptides each, 19 amino acid residues long, with optimal allelic (and potential T. cruzi strain genomic variation) coverage by using PopCover 2.0 method spanning all HLA alleles previously tested. Those peptides will be validated by evaluating T cell response in chronic Chagas disease patient samples. As far as we know, this study represents the most comprehensive immunopeptidomic dataset available for T. cruzi to date. This knowledge holds great promise for understanding adaptive immune activation in chronic Chagas disease and for direct rational discovery of T cell antigens.
Fil: Ferragut, Fatima Eneida del Valle. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Parket, Robert. University of Oxford; Reino Unido
Fil: Ternette, Nicola. University of Oxford; Reino Unido
Fil: Nielsen, Morten. Technical University of Denmark; Dinamarca. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
XXXIV Reunión Anual de la Sociedad Argentina de Protozoología
La Plata
Argentina
Sociedad Argentina de Protozoología
Materia
TRYPANOSOMA CRUZI
T CELL EPITOPES
IMMUNOPEPTIDOME
EPITOPE PREDICTION
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/240690

id CONICETDig_50c3690549ed71d84e219ba6d506d268
oai_identifier_str oai:ri.conicet.gov.ar:11336/240690
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infectionFerragut, Fatima Eneida del ValleParket, RobertTernette, NicolaNielsen, MortenGomez, Karina AndreaTRYPANOSOMA CRUZIT CELL EPITOPESIMMUNOPEPTIDOMEEPITOPE PREDICTIONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1T lymphocyte-mediated immune response against Trypanosoma cruzi (T. cruzi), the parasite causing Chagas disease, is relevant for both parasite control and disease pathogenesis. Therefore, the study of T cells results crucial to the understanding of the immune response in patients and thus contribute to the development of therapies and/or vaccines. However, many challenges are faced when attempting to identify T cell epitopes that can be used for diagnostic or preventive purposes. The complexity of the parasite-host interactions added to the large T. cruzi proteome and the diversity of human leukocyte antigen (HLA) haplotypes in humans hamper the characterization of T cellactivating epitopes, with high population coverage. To date, only a limit number of T. cruzi T cell antigens have been described and only a small proportion of HLA population diversity has been covered. To facilitate this issue, we profiled the repertoire of HLA class I and class II-bound peptides presented by human monocyte-derived macrophages infected or not with T. cruzi. Herein we purified HLA-peptide complexes from infected and uninfected cells and characterized the peptide ligands using LC/MS. For this subset of peptides, the binding to HLA class I and II alleles from THP-1 haplotype was predicted by using MHCMotifDecon1.1, NetMHCpan 4.1a and NetMHCIIpan 4.2 algorithms based on artificial neural network trained with empirical HLA binding and immunopeptidomics data. Our approach allowed us to identify 66 T. cruzi encoded ligands originating from 37 proteins, many of them outside TS proteins and with intracellular localization. Additionally, results showed no difference in length between T. cruzi and uninfected host ligands, thus suggesting that the parasite does not alter antigen processing and presentation machinery in the host cell. For T. cruzi source proteins, 8-12-mer and 12-21-mer peptides were extracted for HLA class I and II, respectively. Binding to a set of 19 HLA-A, 28 HLA-B, 19 HLA-C molecules prevalent in Latin America and 28 HLA-DRB1 alleles, 13 HLADPA1/DPB1 and 36 HLA-DQA1/DQB1 haplotypes were predicted using NetMHCpan 4.1 and NetMHCIIpan 4.1 methods, respectively. Finally, we selected 2 sets of 50 peptides each, 19 amino acid residues long, with optimal allelic (and potential T. cruzi strain genomic variation) coverage by using PopCover 2.0 method spanning all HLA alleles previously tested. Those peptides will be validated by evaluating T cell response in chronic Chagas disease patient samples. As far as we know, this study represents the most comprehensive immunopeptidomic dataset available for T. cruzi to date. This knowledge holds great promise for understanding adaptive immune activation in chronic Chagas disease and for direct rational discovery of T cell antigens.Fil: Ferragut, Fatima Eneida del Valle. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Parket, Robert. University of Oxford; Reino UnidoFil: Ternette, Nicola. University of Oxford; Reino UnidoFil: Nielsen, Morten. Technical University of Denmark; Dinamarca. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaXXXIV Reunión Anual de la Sociedad Argentina de ProtozoologíaLa PlataArgentinaSociedad Argentina de ProtozoologíaSociedad Argentina de Protozoología2023info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/240690Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection; XXXIV Reunión Anual de la Sociedad Argentina de Protozoología; La Plata; Argentina; 2023; 39-392953-5751CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://protozoologia.org.ar/wp-content/uploads/PARASITUS-Volumen-2-2023-ISSN-2953-5751.pdfNacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:59:30Zoai:ri.conicet.gov.ar:11336/240690instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:59:30.984CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
title Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
spellingShingle Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
Ferragut, Fatima Eneida del Valle
TRYPANOSOMA CRUZI
T CELL EPITOPES
IMMUNOPEPTIDOME
EPITOPE PREDICTION
title_short Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
title_full Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
title_fullStr Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
title_full_unstemmed Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
title_sort Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection
dc.creator.none.fl_str_mv Ferragut, Fatima Eneida del Valle
Parket, Robert
Ternette, Nicola
Nielsen, Morten
Gomez, Karina Andrea
author Ferragut, Fatima Eneida del Valle
author_facet Ferragut, Fatima Eneida del Valle
Parket, Robert
Ternette, Nicola
Nielsen, Morten
Gomez, Karina Andrea
author_role author
author2 Parket, Robert
Ternette, Nicola
Nielsen, Morten
Gomez, Karina Andrea
author2_role author
author
author
author
dc.subject.none.fl_str_mv TRYPANOSOMA CRUZI
T CELL EPITOPES
IMMUNOPEPTIDOME
EPITOPE PREDICTION
topic TRYPANOSOMA CRUZI
T CELL EPITOPES
IMMUNOPEPTIDOME
EPITOPE PREDICTION
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv T lymphocyte-mediated immune response against Trypanosoma cruzi (T. cruzi), the parasite causing Chagas disease, is relevant for both parasite control and disease pathogenesis. Therefore, the study of T cells results crucial to the understanding of the immune response in patients and thus contribute to the development of therapies and/or vaccines. However, many challenges are faced when attempting to identify T cell epitopes that can be used for diagnostic or preventive purposes. The complexity of the parasite-host interactions added to the large T. cruzi proteome and the diversity of human leukocyte antigen (HLA) haplotypes in humans hamper the characterization of T cellactivating epitopes, with high population coverage. To date, only a limit number of T. cruzi T cell antigens have been described and only a small proportion of HLA population diversity has been covered. To facilitate this issue, we profiled the repertoire of HLA class I and class II-bound peptides presented by human monocyte-derived macrophages infected or not with T. cruzi. Herein we purified HLA-peptide complexes from infected and uninfected cells and characterized the peptide ligands using LC/MS. For this subset of peptides, the binding to HLA class I and II alleles from THP-1 haplotype was predicted by using MHCMotifDecon1.1, NetMHCpan 4.1a and NetMHCIIpan 4.2 algorithms based on artificial neural network trained with empirical HLA binding and immunopeptidomics data. Our approach allowed us to identify 66 T. cruzi encoded ligands originating from 37 proteins, many of them outside TS proteins and with intracellular localization. Additionally, results showed no difference in length between T. cruzi and uninfected host ligands, thus suggesting that the parasite does not alter antigen processing and presentation machinery in the host cell. For T. cruzi source proteins, 8-12-mer and 12-21-mer peptides were extracted for HLA class I and II, respectively. Binding to a set of 19 HLA-A, 28 HLA-B, 19 HLA-C molecules prevalent in Latin America and 28 HLA-DRB1 alleles, 13 HLADPA1/DPB1 and 36 HLA-DQA1/DQB1 haplotypes were predicted using NetMHCpan 4.1 and NetMHCIIpan 4.1 methods, respectively. Finally, we selected 2 sets of 50 peptides each, 19 amino acid residues long, with optimal allelic (and potential T. cruzi strain genomic variation) coverage by using PopCover 2.0 method spanning all HLA alleles previously tested. Those peptides will be validated by evaluating T cell response in chronic Chagas disease patient samples. As far as we know, this study represents the most comprehensive immunopeptidomic dataset available for T. cruzi to date. This knowledge holds great promise for understanding adaptive immune activation in chronic Chagas disease and for direct rational discovery of T cell antigens.
Fil: Ferragut, Fatima Eneida del Valle. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Parket, Robert. University of Oxford; Reino Unido
Fil: Ternette, Nicola. University of Oxford; Reino Unido
Fil: Nielsen, Morten. Technical University of Denmark; Dinamarca. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
XXXIV Reunión Anual de la Sociedad Argentina de Protozoología
La Plata
Argentina
Sociedad Argentina de Protozoología
description T lymphocyte-mediated immune response against Trypanosoma cruzi (T. cruzi), the parasite causing Chagas disease, is relevant for both parasite control and disease pathogenesis. Therefore, the study of T cells results crucial to the understanding of the immune response in patients and thus contribute to the development of therapies and/or vaccines. However, many challenges are faced when attempting to identify T cell epitopes that can be used for diagnostic or preventive purposes. The complexity of the parasite-host interactions added to the large T. cruzi proteome and the diversity of human leukocyte antigen (HLA) haplotypes in humans hamper the characterization of T cellactivating epitopes, with high population coverage. To date, only a limit number of T. cruzi T cell antigens have been described and only a small proportion of HLA population diversity has been covered. To facilitate this issue, we profiled the repertoire of HLA class I and class II-bound peptides presented by human monocyte-derived macrophages infected or not with T. cruzi. Herein we purified HLA-peptide complexes from infected and uninfected cells and characterized the peptide ligands using LC/MS. For this subset of peptides, the binding to HLA class I and II alleles from THP-1 haplotype was predicted by using MHCMotifDecon1.1, NetMHCpan 4.1a and NetMHCIIpan 4.2 algorithms based on artificial neural network trained with empirical HLA binding and immunopeptidomics data. Our approach allowed us to identify 66 T. cruzi encoded ligands originating from 37 proteins, many of them outside TS proteins and with intracellular localization. Additionally, results showed no difference in length between T. cruzi and uninfected host ligands, thus suggesting that the parasite does not alter antigen processing and presentation machinery in the host cell. For T. cruzi source proteins, 8-12-mer and 12-21-mer peptides were extracted for HLA class I and II, respectively. Binding to a set of 19 HLA-A, 28 HLA-B, 19 HLA-C molecules prevalent in Latin America and 28 HLA-DRB1 alleles, 13 HLADPA1/DPB1 and 36 HLA-DQA1/DQB1 haplotypes were predicted using NetMHCpan 4.1 and NetMHCIIpan 4.1 methods, respectively. Finally, we selected 2 sets of 50 peptides each, 19 amino acid residues long, with optimal allelic (and potential T. cruzi strain genomic variation) coverage by using PopCover 2.0 method spanning all HLA alleles previously tested. Those peptides will be validated by evaluating T cell response in chronic Chagas disease patient samples. As far as we know, this study represents the most comprehensive immunopeptidomic dataset available for T. cruzi to date. This knowledge holds great promise for understanding adaptive immune activation in chronic Chagas disease and for direct rational discovery of T cell antigens.
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Journal
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/240690
Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection; XXXIV Reunión Anual de la Sociedad Argentina de Protozoología; La Plata; Argentina; 2023; 39-39
2953-5751
CONICET Digital
CONICET
url http://hdl.handle.net/11336/240690
identifier_str_mv Moving forward with antigen-specific T cell response in Chagas disease: deciphering the immunopeptidome landscape in Trypanosoma cruzi infection; XXXIV Reunión Anual de la Sociedad Argentina de Protozoología; La Plata; Argentina; 2023; 39-39
2953-5751
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://protozoologia.org.ar/wp-content/uploads/PARASITUS-Volumen-2-2023-ISSN-2953-5751.pdf
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Nacional
dc.publisher.none.fl_str_mv Sociedad Argentina de Protozoología
publisher.none.fl_str_mv Sociedad Argentina de Protozoología
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269583950479360
score 13.13397